Erik Delsing Malmberg

MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells

Edith Schneider, Nicole Pochert, Liam MacPhee et al. · Leukemia · 2019 · 39 citations

Hoxa9 Program, Functional Genomics, Engineering +9

Patient‐tailored analysis of minimal residual disease in acute myeloid leukemia using next‐generation sequencing

Erik Delsing Malmberg, Sara Ståhlman, Anna Rehammar et al. · European Journal Of Haematology · 2016 · 30 citations

Advancing Holistic Review for Faculty Recruitment and Advancement

Toi Blakley Harris, William A. Thomson, Nancy Moreno et al. · Academic Medicine · 2018 · 27 citations

Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations

Erik Delsing Malmberg, Anna Rehammar, Mariana Buongermino Pereira et al. · Journal of Molecular Diagnostics · 2018 · 23 citations · Full text

Bioinformatics, Hematological Malignancy, Engineering +13

Minimal residual disease assessed with deep sequencing of <i>NPM1</i> mutations predicts relapse after allogeneic stem cell transplant in AML

Erik Delsing Malmberg, Sofie Johansson Alm, Malin Nicklasson et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 21 citations · Full text

Pathology, Myeloid Neoplasia, Hematological Malignancy +19